相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Activated Ca2+/calmodulin-dependent protein kinase IIγ is a critical regulator of myeloid leukemia cell proliferation
Jutong Si et al.
CANCER RESEARCH (2008)
BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors
Mhairi Copland et al.
BLOOD (2008)
Role of class II phosphoinositide 3-kinase in cell signalling
M. Falasca et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
AKT-independent phosphorylation of TSC2 and activation of mTOR and ribosomal protein S6 kinase signaling by prostaglandin F2α
Edward W. Arvisais et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib
C Miething et al.
LEUKEMIA (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML)
C Walz et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain
F Heidel et al.
BLOOD (2006)
Growing roles for the mTOR pathway
DD Sarbassov et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Mammalian target of rapamycin as a therapeutic target in leukemia
FJ Giles et al.
CURRENT MOLECULAR MEDICINE (2005)
Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase
SY Ren et al.
EXPERIMENTAL HEMATOLOGY (2005)
Combination of imatinib with rapamycin or RAD001 acts synergistically only in Bcr-Abl-positive cells with moderate resistance to imatinib
J Dengler et al.
LEUKEMIA (2005)
Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development
A Burchert et al.
LEUKEMIA (2005)
Chronic myeloid leukaemia: stem cell derived but progenitor cell driven
SB Marley et al.
CLINICAL SCIENCE (2005)
The mammalian target of rapamycin-p70 ribosomal S6 kinase but not phosphatidylinositol 3-kinase-Akt signaling is responsible for fibroblast growth factor-9-induced cell proliferation
LYC Wing et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
ABL oncogenes and phosphoinositide 3-kinase:: Mechanism of activation and downstream effectors
NG Kharas et al.
CANCER RESEARCH (2005)
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
R Ren
NATURE REVIEWS CANCER (2005)
PI3-kinase and TOR: PIKTORing cell growth
CJ Richardson et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs
MG Mohi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inhibitory effect of imatinib on normal progenitor cells in vitro
K Bartolovic et al.
BLOOD (2004)
Abl: the prototype of oncogenic fusion proteins
G Saglio et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
InBCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C
T Kindler et al.
LEUKEMIA (2003)
Studying the pathogenesis of BCR-ABL+ leukemia in mice
RA Van Etten
ONCOGENE (2002)
Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake
AL Edinger et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice
HJ Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of phospholipase C γ isoforms in haematopoietic cells -: Why one, not the other?
JI Wilde et al.
CELLULAR SIGNALLING (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
